http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100783286-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365
filingDate 2005-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2007-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2007-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-100783286-B1
titleOfInvention Solid pharmaceutical composition containing free base of clopidogrel preferential optical isomer
abstract The present invention relates to a solid clopidogrel preferential optical isomeric pharmaceutical composition containing the free base of the preferred clopidogrel optical isomer in an oil phase.n n n The present invention can structurally stably solidify the oily clopidogrel free base, and can be easily formulated by having a powdery phase with high fluidity.n n n n Priority optical isomers of clopidogrel, stabilizer, silica, clopidogrel free base
priorityDate 2005-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20070002702-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-960003615-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474094
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534242
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426208976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453866747
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453137281
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407364031
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24667
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448352729
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457793542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19758701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485881
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414887584
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579079
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84979
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71587168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16703273
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426080742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14049689
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549665

Total number of triples: 51.